Health Desk-- May 20, 2017: A new discovery claims that diabetics will no longer have to go through painful insulin injections as new anti-diabetes drugs will soon be able to do the needful.
Researchers led by the University of Adelaide have shown how potential anti-diabetic drugs interact with their target in the body at the molecular level.
Diabetes Mellitus is a condition wherein the body is either unable to produce insulin on its own or is not able to use it properly.
John Bruning, from University of Adelaide, said, "Type two diabetes is characterised by resistance to insulin with subsequent high blood sugar which leads to serious disease. It is usually associated with poor lifestyle factors such as diet and lack of exercise".
According to a global media report, the new drug targets a protein receptor known as PPAR gamma found in fat tissue throughout the body, either fully or partially activating it in order to lower blood sugar by increasing sensitivity to insulin and changing the metabolism of fat and sugar.
The new drug, however, doesn't act on the liver to reduce glucose product like most commonly prescribed anti-diabetes drugs like Metformin.